We had the great pleasure of meeting with Tobias Hartmann (Director and Professor of Experimental Neurology, DIDP, Saarland University, Saarbrücken, Germany) to discuss the diet and nutritional interventions in the progress from MCI to dementia.
Part 2 of our discussion can be found here.
The abstract entitled ‘ADCOMS: A Post-Hoc Analysis Using Data from the 3-Year Lipididiet Trial in Prodromal Alzheimer’s Disease’ was presented at The 15th International Conference for Alzheimer’s & Parkinson’s Diseases (Virtual), March 8-14, 2021.
Questions:
- What clinical evidence supports a role for diet and nutritional interventions in the progression from mild cognitive impairment (MCI) to dementia, and what are the limitations of this evidence? (0:17)
- What will be the likely future directions of research into the impact of nutritional interventions? (3:05)
Disclosures: Tobias Hartmann is the Coordinator of LipiDiDiet study; and received a grant for the EU Joint Programme– Neurodegenerative Disease Research (JPND) EURO‐FINGERS.
Support: Interview and filming supported by Touch Medical Media.
Filmed as a highlight of AD/PD Virtual 2021.
